Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment.
about
Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the PI3K/Akt and ERK1/2 pathwaysTargeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.Optimized delivery system achieves enhanced endomyocardial stem cell retention.Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.Prostaglandin E₁ protects bone marrow-derived mesenchymal stem cells against serum deprivation-induced apoptosisDesigning 3D Mesenchymal Stem Cell Sheets Merging Magnetic and Fluorescent Features: When Cell Sheet Technology Meets Image-Guided Cell Therapy.Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction.Electrospun nanofibrous sheets of collagen/elastin/polycaprolactone improve cardiac repair after myocardial infarction.Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fracturesDelivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technologyEmerging therapeutic approaches for multipotent mesenchymal stromal cells.Standardization of models and methods used to assess nanoparticles in cardiovascular applications.Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmapExperience from experimental cell transplantation therapy of myocardial infarction: what have we learned?Mesenchymal stem cell delivery routes and fate.Arrhythmia in stem cell transplantation.Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.Impact of escaped bone marrow mesenchymal stromal cells on extracardiac organs after intramyocardial implantation in a rat myocardial infarction model.Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.Long-Term and Sustained Therapeutic Results of a Specific Promonocyte Cell Formulation in Refractory Angina: ReACT(®) (Refractory Angina Cell Therapy) Clinical Update and Cost-Effective Analysis.The role of nanomaterials in cell delivery systems.Therapeutic Potential of Adipose-Derived Therapeutic Factor Concentrate for Treating Critical Limb Ischemia.Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types
P2860
Q28568062-D73FBCBE-C1A7-4018-A51D-7ABD51B4F285Q33907262-443CBC81-F97F-4972-8D35-73A882FE207CQ34756310-6EEDBAC7-2305-4360-AC07-560CB7F8A5A1Q35524961-45D6FD9A-524D-404B-9848-F706AD1B7B5DQ35739823-62EFE96E-125B-4086-995F-91ABB7EFCDD2Q35972352-A74D32B6-613C-4680-9D0F-BDA7BCF01225Q36506274-F20F2345-335A-442E-A2A0-8AEC6D0C885AQ36578130-36E45107-A398-402E-9F8E-9847246FB8F3Q36879549-8E81E49C-8203-4AA7-997C-F4D6409BCD28Q37294819-62AE0293-4D0A-41DD-AB20-94F68838FD61Q37337649-D12629C2-D4D3-4683-A67F-D99FD751CB73Q37781668-0E3443FF-63B4-4179-B969-67EA98B01C23Q37841416-FB7EB708-222A-4BEF-97DF-9241CDEB1497Q37982370-79F794EB-4ECE-4969-A505-8FF2185D2EF0Q38001505-B2314461-708C-499C-831B-B8C5DA61EF09Q38214088-7A961736-056B-4AC2-9CBF-4215BAE3DEC4Q38499161-6AC24D4A-AF4B-4BD8-AFBE-9DFF3BB16314Q39017865-16097B5C-1B8A-4666-8597-167DD7BECF01Q42933950-481407A7-C7B2-4A06-B2DA-6616489B6C71Q47573004-093EABF6-E7D7-41C3-8633-CBABC2019336Q48076745-7DE4D226-D083-41A3-8F27-B47F26529802Q48244063-845F875B-1148-419D-B4E6-BE539EE59355Q50963784-1935B48F-E31B-4325-8DFC-18DA1C428DE7Q55441937-EF8136BE-8514-4CAD-8DB3-287DA7C7F0CEQ57176906-BA3F225F-00F0-4B5A-9B30-2A434C809675
P2860
Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mesenchymal stem cell administ ...... es: a quantitative assessment.
@en
type
label
Mesenchymal stem cell administ ...... es: a quantitative assessment.
@en
prefLabel
Mesenchymal stem cell administ ...... es: a quantitative assessment.
@en
P2093
P2860
P1433
P1476
Mesenchymal stem cell administ ...... es: a quantitative assessment.
@en
P2093
Joan S Dow
Robert A Kloner
Sharon L Hale
Wangde Dai
P2860
P304
P356
10.1016/J.LFS.2008.07.020
P407
P577
2008-08-09T00:00:00Z